Search Results - "Grassi, Jeffrey M."

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations by Von Moltke, Lisa L., Greenblatt, David J., Granda, Brian W., Duan, Su Xiang, Grassi, Jeffrey M., Venkatakrishnan, Karthik, Harmatz, Jerold S., Shader, Richard I.

    Published in British journal of clinical pharmacology (01-07-1999)
    “…Aims To determine the human cytochromes mediating biotransformation of the imidazopyridine hypnotic, zolpidem, and the clinical correlates of the findings…”
    Get full text
    Journal Article
  2. 2

    INTERACTION OF TRIAZOLAM AND KETOCONAZOLE IN P-GLYCOPROTEIN-DEFICIENT MICE by VON MOLTKE, Lisa L, GRANDA, Brian W, GRASSI, Jeffrey M, PERLOFF, Michael D, VISHNUVARDHAN, Daesety, GREENBLATT, David J

    Published in Drug metabolism and disposition (01-08-2004)
    “…The role of P-glycoprotein (P-gp) on the distribution of the benzodiazepine triazolam (TRZ) and the azole antifungal agent ketoconazole (KET), and on the…”
    Get full text
    Journal Article
  3. 3

    Multiple Human Cytochromes Contribute to Biotransformation of Dextromethorphan In-vitro: Role of CYP2C9, CYP2C19, CYP2D6, and CYP3A by Von Moltke, Lisa L., Greenblatt, David J., Grassi, Jeffrey M., Granda, Brian W., Venkatakrishnan, Karthik, Schmider, JÜRgen, Harmatz, Jerold S., Shader, Richard I.

    Published in Journal of pharmacy and pharmacology (01-09-1998)
    “…Cytochromes mediating the biotransformation of dextromethorphan to dextrorphan and 3‐methoxymorphinan, its principal metabolites in man, have been studied by…”
    Get full text
    Journal Article
  4. 4

    Acute zolpidem administration produces pharmacodynamic and receptor occupancy changes at similar doses by Fahey, Jeanne M., Grassi, Jeffrey M., Reddi, Jyoti M., Greenblatt, David J.

    “…Zolpidem is chemically unrelated to classical benzodiazepines but has demonstrated relatively high affinity binding to the α 1 GABA A receptor. To assess…”
    Get full text
    Journal Article
  5. 5

    The effect of chronic lorazepam administration in aging mice by Fahey, Jeanne M., Pritchard, Gary A., Reddi, Jyoti M., Pratt, John S., Grassi, Jeffrey M., Shader, Richard I., Greenblatt, David J.

    Published in Brain research (06-11-2006)
    “…To assess benzodiazepine tolerance in aged animals, lorazepam or vehicle was administered chronically to male Crl: CD-1(ICR)BR mice. Pharmacodynamic and…”
    Get full text
    Journal Article
  6. 6

    Citalopram and desmethylcitalopram in vitro: human cytochromes mediating transformation, and cytochrome inhibitory effects by von Moltke, Lisa L., Greenblatt, David J., Grassi, Jeffrey M., Granda, Brian W., Venkatakrishnan, Karthik, Duan, Su Xiang, Fogelman, Steven M., Harmatz, Jerold S., Shader, Richard I.

    Published in Biological psychiatry (1969) (15-09-1999)
    “…Background: Biotransformation of citalopram (CT), a newly available selective serotonin reuptake inhibitor antidepressant, to its principal metabolite,…”
    Get full text
    Journal Article
  7. 7

    Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro : cytochromes mediating transformation, and P450-3A4 inhibitory actions by VON MOLTKE, L. L, GREENBLATT, D. J, GRANDA, B. W, GRASSI, J. M, SCHMIDER, J, HARMATZ, J. S, SHADER, R. I

    Published in Psychopharmacologia (01-07-1999)
    “…Understanding of the mechanisms of biotransformation of antidepressant drugs, and of their capacity to interact with other medications, is of direct relevance…”
    Get full text
    Journal Article
  8. 8

    Pharmacodynamic and receptor binding changes during chronic lorazepam administration by Fahey, Jeanne M, Pritchard, Gary A, Grassi, Jeffrey M, Pratt, John S, Shader, Richard I, Greenblatt, David J

    Published in Pharmacology, biochemistry and behavior (01-05-2001)
    “…To assess pharmacodynamic and neurochemical aspects of tolerance, lorazepam (2 mg/kg/day), or vehicle was administered chronically to male Crl: CD-1(ICR)BR…”
    Get full text
    Journal Article
  9. 9

    Effects of ketoconazole on triazolam pharmacokinetics, pharmacodynamics and benzodiazepine receptor binding in mice by Fahey, J M, Pritchard, G A, Moltke, L L, Pratt, J S, Grassi, J M, Shader, R I, Greenblatt, D J

    “…We previously demonstrated that ketoconazole is a potent inhibitor of triazolam biotransformation in vitro and in vivo. Despite significant elevations in…”
    Get more information
    Journal Article
  10. 10

    In situ hybridization histochemistry as a method to assess GABAAreceptor subunit mRNA expression following chronic alprazolam administration by Fahey, Jeanne M., Pritchard, Gary A., Grassi, Jeffrey M., Pratt, John S., Shader, Richard I., Greenblatt, David J.

    Published in Journal of psychopharmacology (Oxford) (01-05-1999)
    “…Previous work in our laboratory has demonstrated region-specic effects for chronic alprazolam on binding and function at the GABAA receptor. The present study…”
    Get full text
    Journal Article
  11. 11

    Protease Inhibitors as Inhibitors of Human Cytochromes P450: High Risk Associated with Ritonavir by von Moltke, Lisa L., Greenblatt, David J., Grassi, Jeffrey M., Granda, Brian W., Duan, Su Xiang, Fogelman, Steven M., Daily, Johanna P., Harmatz, Jerold S., Shader, Richard I.

    Published in Journal of clinical pharmacology (01-02-1998)
    “…Four protease inhibitor antiviral agents (ritonavir, indinavir, nelfinavir, saquinavir) were evaluated as in vitro inhibitors of the activity of six human…”
    Get full text
    Journal Article
  12. 12

    In situ hybridization histochemistry as a method to assess GABA(A) receptor subunit mRNA expression following chronic alprazolam administration by Fahey, J M, Pritchard, G A, Grassi, J M, Pratt, J S, Shader, R I, Greenblatt, D J

    “…Previous work in our laboratory has demonstrated region-specific effects for chronic alprazolam on binding and function at the GABA(A) receptor. The present…”
    Get full text
    Journal Article
  13. 13

    Appetite suppressant drugs as inhibitors of human cytochromes p450 : In vitro inhibition of P450-2D6 by D- and L-fenfluramine, but not phentermine by VON MOLTKE, L. L, GREENBLATT, D. J, CIRAULO, D. A, GRASSI, J. M, GRANDA, B. W, SU XIANG DUAN, HARMATZ, J. S, SHADER, R. I

    Published in Journal of clinical psychopharmacology (01-08-1998)
    “…The activity of D-fenfluramine, L-fenfluramine, and phentermine as inhibitors of five human cytochromes P450 was evaluated using human liver microsomes in…”
    Get full text
    Journal Article